Arjan van de Loosdrecht

PROF.DR., (Principal Investigator)

20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
  • Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?

    Duetz, C., Bachas, C., Westers, T. M. & van de Loosdrecht, A. A., Mar 2020, In : Current Opinion in Oncology. 32, 2, p. 162-169 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  • Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)

    Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., Van der Klift, M. & 69 others, Van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B., Breems, D. A., Havelange, Vekemans, M. C., Moors, I., van Obberg, F., Maertens, J. A., Hodossy, B., Vansteenweghen, S., Lammertijn, L., Deeren, D., Graux, C., Sonet, A., Triffet, A., Gjertsen, B. T., Bargetzi, M., Passweg, J., Heim, D., Giovanni, S., Stuessi, G., Pabst, T., Betticher, D., Chalandon, Y., Spertini, O., Gregor, M., Hess, U., Fehr, M., Manz, M. G., Klein, S. K., Biemond, B. J., Ossenkoppele, G. J., van de Loosdrecht, A., Janssen, J. J. W. M., van Esser, J. W. J., Van der Klift, M., Brouwer, R. E., Van Lammeren-Venema, D., Levin, M. D., Tick, L. W., Legdeur, M. C. J. C., Huls, G., Vellenga, E., Hoogendoorn, M., Veelken, J. H., von dem Borne, P. A., Schouten, H. C., de Weerdt, O., van der Velden, W. J. F. M., Cornelissen, J., Jongen-Lavrencic, M., Wouters, B., Raaijmakers, H. G. M., Löwenberg, B., Kuball, J., Van Rhenen, A., Van Marwijk Kooy, M. & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Oct 2020, In : Leukemia. 34, 10, 1 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

    Open Access
  • Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

    Huls, G., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Valk, P. J. M., Cloos, J., van de Loosdrecht, A. A., Breems, D., van Lammeren-Venema, D., van Zeventer, I., Boersma, R., Jongen-Lavrencic, M., Fehr, M., Hoogendoorn, M., Manz, M. G., Söhne, M., Kooy, R. V. M., Deeren, D. & 8 others, van der Poel, M. W. M., Legdeur, M. C., Tick, L., Chalandon, Y., Ammatuna, E., Blum, S., Löwenberg, B. & Ossenkoppele, G. J., 1 Sep 2020, In : Blood. 4, 18, p. 4267-4277 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

    Open Access
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Bernard, E., Nannya, Y., Hasserjian, R. P., Devlin, S. M., Tuechler, H., Medina-Martinez, J. S., Yoshizato, T., Shiozawa, Y., Saiki, R., Malcovati, L., Levine, M. F., Arango, J. E., Zhou, Y., Solé, F., Cargo, C. A., Haase, D., Creignou, M., Germing, U., Zhang, Y., Gundem, G. & 59 others, Sarian, A., van de Loosdrecht, A. A., Jädersten, M., Tobiasson, M., Kosmider, O., Follo, M. Y., Thol, F., Pinheiro, R. F., Santini, V., Kotsianidis, I., Boultwood, J., Santos, F. P. S., Schanz, J., Kasahara, S., Ishikawa, T., Tsurumi, H., Takaori-Kondo, A., Kiguchi, T., Polprasert, C., Bennett, J. M., Klimek, V. M., Savona, M. R., Belickova, M., Ganster, C., Palomo, L., Sanz, G., Ades, L., Della Porta, M. G., Smith, A. G., Werner, Y., Patel, M., Viale, A., Vanness, K., Neuberg, D. S., Stevenson, K. E., Menghrajani, K., Bolton, K. L., Fenaux, P., Pellagatti, A., Platzbecker, U., Heuser, M., Valent, P., Chiba, S., Miyazaki, Y., Finelli, C., Voso, M. T., Shih, L. Y., Fontenay, M., Jansen, J. H., Cervera, J., Atsuta, Y., Gattermann, N., Ebert, B. L., Bejar, R., Greenberg, P. L., Cazzola, M., Hellström-Lindberg, E., Ogawa, S. & Papaemmanuil, E., 1 Oct 2020, In : Nature Medicine. 26, 10, p. 1549-1556 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  • Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

    Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B. T., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., Van der Klift, M. & 14 others, Van Marwijk Kooy, M., Maertens, J., Micheaux, L., van der Poel, M. W. M., Van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B. & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Jan 2020, In : Leukemia. 34, 7, 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

If you made any changes in Pure these will be visible here soon.